SCHEMBL7550368

SCHEMBL7550368

CCN(CCn1cc(-c2cncc(-c3ccsc3)c2)c2ccccc21)Cc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.73
FLT1 P17948 4/20 0.61
FLT4 P35916 4/20 0.61
CYP2A6 P11509 2/20 0.38
MAOB P27338 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.36
KCNH2 Q12809 1/20 0.36
DYRK1A Q13627 1/20 0.36
SQLE Q14534 1/20 0.35
CAMK2D Q13557 1/20 0.35
PRKCA P17252 1/20 0.35
HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7554970 0.93 KDR (0.81) KDRFLT1FLT4CYP2A6DYRK1A
SCHEMBL7976107 0.90 KDR (0.68) KDRFLT1FLT4CYP2A6SIRT2
SCHEMBL7551626 0.89 KDR (0.79) KDRFLT1FLT4CYP2A6MAOB
SCHEMBL7550287 0.85 KDR (1.00) KDRFLT1FLT4CYP2A6PRKCA
SCHEMBL7549872 0.83 KDR (0.81) KDRFLT1FLT4CYP2A6KCNH2
SCHEMBL7553991 0.81 KDR (1.00) KDRFLT1FLT4CYP2A6SIRT2
SCHEMBL7555190 0.76 KDR (1.00) KDRFLT1FLT4CYP2A6DYRK1A
SCHEMBL7556531 0.75 KDR (1.00) KDRFLT1FLT4CYP2A6DYRK1A
SCHEMBL7549908 0.75 KDR (1.00) KDRFLT1FLT4CYP2A6DYRK1A
SCHEMBL7506453 0.74 KDR (1.00) KDRFLT1FLT4DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed